256 related articles for article (PubMed ID: 30149230)
1. Nanotopography-responsive myotube alignment and orientation as a sensitive phenotypic biomarker for Duchenne Muscular Dystrophy.
Xu B; Magli A; Anugrah Y; Koester SJ; Perlingeiro RCR; Shen W
Biomaterials; 2018 Nov; 183():54-66. PubMed ID: 30149230
[TBL] [Abstract][Full Text] [Related]
2. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
[TBL] [Abstract][Full Text] [Related]
3. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
[TBL] [Abstract][Full Text] [Related]
4. Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells.
Shoji E; Sakurai H; Nishino T; Nakahata T; Heike T; Awaya T; Fujii N; Manabe Y; Matsuo M; Sehara-Fujisawa A
Sci Rep; 2015 Aug; 5():12831. PubMed ID: 26290039
[TBL] [Abstract][Full Text] [Related]
5. Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model.
Choi IY; Lim H; Estrellas K; Mula J; Cohen TV; Zhang Y; Donnelly CJ; Richard JP; Kim YJ; Kim H; Kazuki Y; Oshimura M; Li HL; Hotta A; Rothstein J; Maragakis N; Wagner KR; Lee G
Cell Rep; 2016 Jun; 15(10):2301-2312. PubMed ID: 27239027
[TBL] [Abstract][Full Text] [Related]
6. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro.
Vieira NM; Brandalise V; Zucconi E; Jazedje T; Secco M; Nunes VA; Strauss BE; Vainzof M; Zatz M
Biol Cell; 2008 Apr; 100(4):231-41. PubMed ID: 17997718
[TBL] [Abstract][Full Text] [Related]
7. Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients.
Meyer P; Notarnicola C; Meli AC; Matecki S; Hugon G; Salvador J; Khalil M; Féasson L; Cances C; Cottalorda J; Desguerre I; Cuisset JM; Sabouraud P; Lacampagne A; Chevassus H; Rivier F; Carnac G
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884796
[TBL] [Abstract][Full Text] [Related]
8. Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy.
Wuebbles RD; Sarathy A; Kornegay JN; Burkin DJ
Dis Model Mech; 2013 Sep; 6(5):1175-84. PubMed ID: 23846963
[TBL] [Abstract][Full Text] [Related]
9. A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCs.
Uchimura T; Asano T; Nakata T; Hotta A; Sakurai H
Cell Rep Med; 2021 Jun; 2(6):100298. PubMed ID: 34195678
[TBL] [Abstract][Full Text] [Related]
10. De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle.
Ebrahimi M; Lad H; Fusto A; Tiper Y; Datye A; Nguyen CT; Jacques E; Moyle LA; Nguyen T; Musgrave B; Chávez-Madero C; Bigot A; Chen C; Turner S; Stewart BA; Pegoraro E; Vitiello L; Gilbert PM
Acta Biomater; 2021 Sep; 132():227-244. PubMed ID: 34048976
[TBL] [Abstract][Full Text] [Related]
11. Effects of Mini-Dystrophin on Dystrophin-Deficient, Human Skeletal Muscle-Derived Cells.
Meng J; Counsell J; Morgan JE
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998454
[TBL] [Abstract][Full Text] [Related]
12. Acute conversion of patient-derived Duchenne muscular dystrophy iPSC into myotubes reveals constitutive and inducible over-activation of TGFβ-dependent pro-fibrotic signaling.
Caputo L; Granados A; Lenzi J; Rosa A; Ait-Si-Ali S; Puri PL; Albini S
Skelet Muscle; 2020 May; 10(1):13. PubMed ID: 32359374
[TBL] [Abstract][Full Text] [Related]
13. Prednisolone rescues Duchenne muscular dystrophy phenotypes in human pluripotent stem cell-derived skeletal muscle in vitro.
Al Tanoury Z; Zimmerman JF; Rao J; Sieiro D; McNamara HM; Cherrier T; Rodríguez-delaRosa A; Hick-Colin A; Bousson F; Fugier-Schmucker C; Marchiano F; Habermann B; Chal J; Nesmith AP; Gapon S; Wagner E; Gupta VA; Bassel-Duby R; Olson EN; Cohen AE; Parker KK; Pourquié O
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34260377
[TBL] [Abstract][Full Text] [Related]
14. A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells.
Young CS; Hicks MR; Ermolova NV; Nakano H; Jan M; Younesi S; Karumbayaram S; Kumagai-Cresse C; Wang D; Zack JA; Kohn DB; Nakano A; Nelson SF; Miceli MC; Spencer MJ; Pyle AD
Cell Stem Cell; 2016 Apr; 18(4):533-40. PubMed ID: 26877224
[TBL] [Abstract][Full Text] [Related]
15. Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion.
Gonçalves MA; de Vries AA; Holkers M; van de Watering MJ; van der Velde I; van Nierop GP; Valerio D; Knaän-Shanzer S
Hum Mol Genet; 2006 Jan; 15(2):213-21. PubMed ID: 16321987
[TBL] [Abstract][Full Text] [Related]
16. Functional significance of gain-of-function H19 lncRNA in skeletal muscle differentiation and anti-obesity effects.
Li Y; Zhang Y; Hu Q; Egranov SD; Xing Z; Zhang Z; Liang K; Ye Y; Pan Y; Chatterjee SS; Mistretta B; Nguyen TK; Hawke DH; Gunaratne PH; Hung MC; Han L; Yang L; Lin C
Genome Med; 2021 Aug; 13(1):137. PubMed ID: 34454586
[TBL] [Abstract][Full Text] [Related]
17. Contractile Activity of Myotubes Derived from Human Induced Pluripotent Stem Cells: A Model of Duchenne Muscular Dystrophy.
Yoshioka K; Ito A; Horie M; Ikeda K; Kataoka S; Sato K; Yoshigai T; Sakurai H; Hotta A; Kawabe Y; Kamihira M
Cells; 2021 Sep; 10(10):. PubMed ID: 34685536
[TBL] [Abstract][Full Text] [Related]
18. SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy.
Sarathy A; Wuebbles RD; Fontelonga TM; Tarchione AR; Mathews Griner LA; Heredia DJ; Nunes AM; Duan S; Brewer PD; Van Ry T; Hennig GW; Gould TW; Dulcey AE; Wang A; Xu X; Chen CZ; Hu X; Zheng W; Southall N; Ferrer M; Marugan J; Burkin DJ
Mol Ther; 2017 Jun; 25(6):1395-1407. PubMed ID: 28391962
[TBL] [Abstract][Full Text] [Related]
19. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
[TBL] [Abstract][Full Text] [Related]
20. Myogenesis modelled by human pluripotent stem cells: a multi-omic study of Duchenne myopathy early onset.
Mournetas V; Massouridès E; Dupont JB; Kornobis E; Polvèche H; Jarrige M; Dorval ARL; Gosselin MRF; Manousopoulou A; Garbis SD; Górecki DC; Pinset C
J Cachexia Sarcopenia Muscle; 2021 Feb; 12(1):209-232. PubMed ID: 33586340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
